Fapon Biotech Partners with Sansure to Develop Next-Generation Diagnostic Solutions
CompanyDeals

Fapon Biotech Partners with Sansure to Develop Next-Generation Diagnostic Solutions

AstraZeneca Officially Launches Fasenra for Severe Eosinophilic Asthma in China
CompanyDrug

AstraZeneca Officially Launches Fasenra for Severe Eosinophilic Asthma in China

United Laboratories Inks Global Licensing Deal with Novo Nordisk for Obesity Drug
CompanyDeals

United Laboratories Inks Global Licensing Deal with Novo Nordisk for Obesity Drug

Fapon Biotech Partners with Tencent Healthcare to Boost IVD and Medical Device Fields
CompanyDeals

Fapon Biotech Partners with Tencent Healthcare to Boost IVD and Medical Device Fields

Joint Biosciences' OVV-01 Receives FDA Fast Track Designation for Soft Tissue Sarcoma Trial
CompanyDrug

Joint Biosciences’ OVV-01 Receives FDA Fast Track Designation for Soft Tissue Sarcoma Trial

Sino Biopharmaceutical's Culmerciclib Shows Positive Results in Phase III Breast Cancer Trial
CompanyDrug

Sino Biopharmaceutical’s Culmerciclib Shows Positive Results in Phase III Breast Cancer Trial

Humanwell Healthcare Receives NMPA Approval for Caplyta Generic in Schizophrenia Trial
CompanyDrug

Humanwell Healthcare Receives NMPA Approval for Caplyta Generic in Schizophrenia Trial

Clover Biopharmaceuticals Receives Termination Notice from GAVI for COVID-19 Vaccine Agreement
Company

Clover Biopharmaceuticals Receives Termination Notice from GAVI for COVID-19 Vaccine Agreement

Simcere Pharmaceutical Group Reports Steady Revenue Amid R&D Investment Shift
Company

Simcere Pharmaceutical Group Reports Steady Revenue Amid R&D Investment Shift

Henlius Biotech Reports 6.1% Revenue Growth with Strong Oncology Product Sales
Company

Henlius Biotech Reports 6.1% Revenue Growth with Strong Oncology Product Sales

Sichuan Kelun-Biotech Reports 25.5% Revenue Growth with Key Drug Approvals
Company

Sichuan Kelun-Biotech Reports 25.5% Revenue Growth with Key Drug Approvals

China's NHSA Releases 2024 Healthcare Security Bulletin Highlighting Insurance Coverage and Reimbursement
DrugMedical Device

China’s NHSA Releases 2024 Healthcare Security Bulletin Highlighting Insurance Coverage and Reimbursement